pre-update Archives

Blog

How the Simcyp Discovery Simulator will Accelerate Early Drug Development

Physiologically-based pharmacokinetic (PBPK) modeling is a technique used to predict the absorption, distribution, metabolism, and…

CertaraJuly 19, 2022

Video

Certara DIA Software Promo

CertaraJuly 18, 2022

Brochure

Simcyp Discovery Simulator

Tailored for discovery and translational scientists, Simcyp Discovery Simulator is an intuitive software that delivers…

CertaraJuly 14, 2022

Press Release

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

PRINCETON, N.J.— July 12, 2022-- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…

CertaraJuly 12, 2022

Blog

Highlights from the FDA-ASCO Workshop on Dose Optimization for Oncology Drugs

The FDA-ASCO (American Society of Clinical Oncology) workshop on oncology dose optimization (3-5 May 2022)…

CertaraJuly 8, 2022

On-Demand Webinar

Using Clinical Pharmacology & Pharmacometrics to Accelerate Cell Therapy Development: A Patient’s CAR-T Journey

Cell therapies aim to treat, prevent, or potentially cure diseases. They are a relatively new…

CertaraJuly 8, 2022

Blog

Why FDA’s New Guidance on Circulating Tumor DNA is Critical for Oncology Early Clinical Drug Development

2022 is shaping up to be the “year of the guidance” as the FDA has…

CertaraJuly 1, 2022

White Paper

Axendia: Improving Healthcare Outcomes by Rewarding Value, NOT Cost

This research examines the use of value-based communications to support the transition to fee-for-outcomes models…

CertaraJune 28, 2022

Video

Certara’s Simcyp Discovery Demo

View this software demo by Dr. Hannah Jones to learn about how Simcyp Discovery provides…

CertaraJune 28, 2022

Brochure

Writing at Lightspeed: Optimizing Submission Dossiers in Today’s Environment Through Better Planning

CertaraJune 24, 2022

pre-update

How the Simcyp Discovery Simulator will Accelerate Early Drug Development

Certara DIA Software Promo

Simcyp Discovery Simulator

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

Highlights from the FDA-ASCO Workshop on Dose Optimization for Oncology Drugs

Using Clinical Pharmacology & Pharmacometrics to Accelerate Cell Therapy Development: A Patient’s CAR-T Journey

Why FDA’s New Guidance on Circulating Tumor DNA is Critical for Oncology Early Clinical Drug Development

Axendia: Improving Healthcare Outcomes by Rewarding Value, NOT Cost

Certara’s Simcyp Discovery Demo

Writing at Lightspeed: Optimizing Submission Dossiers in Today’s Environment Through Better Planning

Newsletter sign up

Quick links

Solutions

Contact